Altered fecal microbiota composition in patients with major depressive disorder

Brain, Behavior, and Immunity

Volumn 48, Issue , 2015, Pages 186-194

  Jiang, Haiyin ^a   Ling, Zongxin ^a   Zhang, Yonghua ^b   Mao, Hongjin ^b   Ma, Zhanping ^c   Yin, Yan ^b   Wang, Weihong ^d   Tang, Wenxin ^b   Tan, Zhonglin ^b   Shi, Jianfei ^b   Li, Lanjuan ^a   Ruan, Bing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Seventh Hospital of HangZhou   (China)

^c Hengshui Cardiovascular Hospital   (China)

^d HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Antidepressant; Depression; Gut bacteria; Gut brain; Inflammation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ACTINOBACTERIA; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTEROIDETES; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FAECALIBACTERIUM; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FIRMICUTES; HIGH THROUGHPUT SEQUENCING; HUMAN; MAJOR DEPRESSION; MALE; MICROBIAL DIVERSITY; MICROBIOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOBACTERIA; PYROSEQUENCING; TAXONOMY; ADOLESCENT; FECES; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER, MAJOR; FECES; FEMALE; HUMANS; MALE; MICROBIOTA; YOUNG ADULT;

EID: 84942984411     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.03.016     Document Type: Article

References (54)

1. Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., Houdeau, E., Fioramonti, J., Bueno, L., Theodorou, V., 2012. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885-1895.
2. Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V., Tompkins, T., 2014. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 26, 510-520.
3. Bailey, M.T., Dowd, S.E., Galley, J.D., Hufnagle, A.R., Allen, R.G., Lyte, M., 2011. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25, 397-407.
4. Bangsgaard Bendtsen, K.M., Krych, L., Sorensen, D.B., Pang, W., Nielsen, D.S., Josefsen, K., Hansen, L.H., Sorensen, S.J., Hansen, A.K., 2012. Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One 7, e46231.
5. Bercik, P., Verdu, E.F., Foster, J.A., Macri, J., Potter, M., Huang, X., Malinowski, P., Jackson, W., Blennerhassett, P., Neufeld, K.A., Lu, J., Khan, W.I., Corthesy-Theulaz, I., Cherbut, C., Bergonzelli, G.E., Collins, S.M., 2010. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139 (2102-2112), e2101.
6. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F., Collins, S.M., 2011. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599-609, 609 e591-593.
7. Berg, R.D., Garlington, A.W., 1979. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect. Immun. 23, 403-411.
8. Berk, M., Williams, L.J., Jacka, F.N., O'Neil, A., Pasco, J.A., Moylan, S., Allen, N.B., Stuart, A.L., Hayley, A.C., Byrne, M.L., Maes, M., 2013. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 11, 200.
9. Bervoets, L., Van Hoorenbeeck, K., Kortleven, I., Van Noten, C., Hens, N., Vael, C., Goossens, H., Desager, K.N., Vankerckhoven, V., 2013. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog. 5, 10.
10. Butnoriene, J., Bunevicius, A., Norkus, A., Bunevicius, R., 2014. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 40, 269-276.
11. Collins, S.M., Surette, M., Bercik, P., 2012. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735-742.
12. Cryan, J.F., Dinan, T.G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701-712.
13. Davey, K.J., O'Mahony, S.M., Schellekens, H., O'Sullivan, O., Bienenstock, J., Cotter, P.D., Dinan, T.G., Cryan, J.F., 2012. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221, 155-169.
14. Davey, K.J., Cotter, P.D., O'Sullivan, O., Crispie, F., Dinan, T.G., Cryan, J.F., O'Mahony, S.M., 2013. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl. Psychiatry 3, e309.
15. Dinan, T.G., Cryan, J.F., 2013. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol. Motil. 25, 713-719.
16. Dinan, T.G., Stanton, C., Cryan, J.F., 2013. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720-726.
17. Duncan, S.H., Louis, P., Flint, H.J., 2007. Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 44, 343-350.
18. Fan, W., Huo, G., Li, X., Yang, L., Duan, C., 2014. Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life. J. Microbiol. Biotechnol. 24, 133-143.
19. Finegold, S.M., Dowd, S.E., Gontcharova, V., Liu, C., Henley, K.E., Wolcott, R.D., Youn, E., Summanen, P.H., Granpeesheh, D., Dixon, D., Liu, M., Molitoris, D.R., Green 3rd, J.A., 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16, 444-453.
20. First, M.B., Spitzer, R., Gibbon, M., Williams, J.B.W., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Publishing, Washington, DC.
21. Goehler, L.E., Park, S.M., Opitz, N., Lyte, M., Gaykema, R.P., 2008. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 22, 354-366.
22. Hamilton, M., 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62.
23. Hiles, S.A., Baker, A.L., de Malmanche, T., Attia, J., 2012. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol. Med. 42, 2015-2026.
24. Jeffery, I.B., O'Toole, P.W., Ohman, L., Claesson, M.J., Deane, J., Quigley, E.M., Simren, M., 2012. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61, 997-1006.
25. Kramer, M.S., Aboud, F., Mironova, E., Vanilovich, I., Platt, R.W., Matush, L., Igumnov, S., Fombonne, E., Bogdanovich, N., Ducruet, T., Collet, J.P., Chalmers, B., Hodnett, E., Davidovsky, S., Skugarevsky, O., Trofimovich, O., Kozlova, L., Shapiro, S.Promotion of Breastfeeding Intervention Trial Study, G., 2008. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch. Gen. Psychiatry 65, 578-584.
26. Ling, Z., Li, Z., Liu, X., Cheng, Y., Luo, Y., Tong, X., Yuan, L., Wang, Y., Sun, J., Li, L., Xiang, C., 2014. Altered fecal microbiota composition associated with food allergy in infants. Appl. Environ. Microbiol. 80, 2546-2554.
27. Lopresti, A.L., Maker, G.L., Hood, S.D., Drummond, P.D., 2014. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog. Neuropsychopharmacol. Biol. Psychiatry 48, 102-111.
28. Lowe, B., Andresen, V., Fraedrich, K., Gappmayer, K., Wegscheider, K., Treszl, A., Riegel, B., Rose, M., Lohse, A.W., Broicher, W., 2014. Psychological outcome, fatigue, and quality of life after infection with shiga toxin-producing Escherichia coli O104. Clin. Gastroenterol. hepatol.
29. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230.
30. Lyte, M., Varcoe, J.J., Bailey, M.T., 1998. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol. Behav. 65, 63-68.
31. Lyte, M., Li, W., Opitz, N., Gaykema, R.P., Goehler, L.E., 2006. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 89, 350-357.
32. Maes, M., Kubera, M., Leunis, J.C., 2008. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 29, 117-124.
33. Maes, M., Kubera, M., Leunis, J.C., Berk, M., 2012. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 141, 55-62.
34. Maes, M., Kubera, M., Leunis, J.C., Berk, M., Geffard, M., Bosmans, E., 2013. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 127, 344-354.
35. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M., Cazaubiel, J.M., 2011. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105, 755-764.
36. Montgomery, S.A., Asberg, M., 1979. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382-389.
37. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., Ustun, B., 2007. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851-858.
38. Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linlokken, A., Wilson, R., Rudi, K., 2014. Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26, 1155-1162.
39. Neufeld, K.M., Kang, N., Bienenstock, J., Foster, J.A., 2011. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 23 (255-264), e119.
40. O'Mahony, S.M., Marchesi, J.R., Scully, P., Codling, C., Ceolho, A.M., Quigley, E.M., Cryan, J.F., Dinan, T.G., 2009. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65, 263-267.
41. O'Malley, D., Julio-Pieper, M., Gibney, S.M., Dinan, T.G., Cryan, J.F., 2010. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour. Stress 13, 114-122.
42. Roger, L.C., Costabile, A., Holland, D.T., Hoyles, L., McCartney, A.L., 2010. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156, 3329-3341.
43. Rook, G.A., Lowry, C.A., 2008. The hygiene hypothesis and psychiatric disorders. Trends Immunol. 29, 150-158.
44. Rook, G.A., Raison, C.L., Lowry, C.A., 2014. Microbial 'old friends', immunoregulation and socioeconomic status. Clin. Exp. Immunol. 177, 1-12.
45. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D., Niederehe, G., Thase, M.E., Lavori, P.W., Lebowitz, B.D., McGrath, P.J., Rosenbaum, J.F., Sackeim, H.A., Kupfer, D.J., Luther, J., Fava, M., 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR/D report. Am. J. Psychiatry 163, 1905-1917.
46. Saulnier, D.M., Riehle, K., Mistretta, T.A., Diaz, M.A., Mandal, D., Raza, S., Weidler, E.M., Qin, X., Coarfa, C., Milosavljevic, A., Petrosino, J.F., Highlander, S., Gibbs, R., Lynch, S.V., Shulman, R.J., Versalovic, J., 2011. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141, 1782-1791.
47. Savignac, H.M., Kiely, B., Dinan, T.G., Cryan, J.F., 2014. Bifidobacteria exert strainspecific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol. Motil. 26, 1615-1627.
48. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (Suppl. 20), 22-33, quiz 34-57.
49. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H.M., Dore, J., Marteau, P., Seksik, P., Langella, P., 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736.
50. Song, Y., Kononen, E., Rautio, M., Liu, C., Bryk, A., Eerola, E., Finegold, S.M., 2006. Alistipes onderdonkii sp. nov. and Alistipes shahii sp. nov., of human origin. Int. J. Syst. Evol. Microbiol. 56, 1985-1990.
51. Vince, A.J., McNeil, N.I., Wager, J.D., Wrong, O.M., 1990. The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system. Br. J. Nutr. 63, 17-26.
52. Wang, Y., Kasper, L.H., 2014. The role of microbiome in central nervous system disorders. Brain Behav. Immun. 38, 1-12.
53. Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., Jenkins, D.J., 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243.
54. Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., Ji, L., 2013. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8, e71108.